Trademark Overview
On Wednesday, May 13, 2026, a trademark application was filed for KEBITAY with the United States Patent and Trademark Office. The USPTO has given the KEBITAY trademark a serial number of 99820420. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 13, 2026. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The KEBITAY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity